AN OPEN-LABELED, OBSERVATIONAL STUDY FOR THE SATISFACTION AND PREFERENCE OF THE RIVASTIGMINE PATCH FOR TREATMENT OF ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE DEMENTIA (SAFE-ADPD) IN KOREANS

Mee Young Park; Dong Seung Shin

首页> 外文期刊>Alzheimer’s & dementia: the journal of the Alzheimer’s Association >AN OPEN-LABELED, OBSERVATIONAL STUDY FOR THE SATISFACTION AND PREFERENCE OF THE RIVASTIGMINE PATCH FOR TREATMENT OF ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE DEMENTIA (SAFE-ADPD) IN KOREANS

【24h】

AN OPEN-LABELED, OBSERVATIONAL STUDY FOR THE SATISFACTION AND PREFERENCE OF THE RIVASTIGMINE PATCH FOR TREATMENT OF ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE DEMENTIA (SAFE-ADPD) IN KOREANS

机译：用于治疗阿尔茨米尔疾病和帕金森病痴呆（Safe-Adpd）在韩国人的满意和偏好的开放式观察性研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Alzheimer’s & dementia: the journal of the Alzheimer’s Association 》 |2018年第7期| 共1页
作者
Mee Young Park; Dong Seung Shin;
展开▼
作者单位

Yeungnam University Medical Center;

Yeungnam University Medical Center;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学 ;
关键词

相似文献

外文文献
中文文献
专利

1. AN OPEN-LABELED, OBSERVATIONAL STUDY FOR THE SATISFACTION AND PREFERENCE OF THE RIVASTIGMINE PATCH FOR TREATMENT OF ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE DEMENTIA (SAFE-ADPD) IN KOREANS [J] . Mee Young Park, Dong Seung Shin Alzheimer’s & dementia: the journal of the Alzheimer’s Association . 2018 ,第7期

机译：用于治疗阿尔茨米尔疾病和帕金森病痴呆（Safe-Adpd）在韩国人的满意和偏好的开放式观察性研究
2. Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study. [J] . Poewe W, Wolters E, Emre M, Movement disorders . 2006 ,第4期

机译：利凡斯的明在与帕金森氏病相关的痴呆中的长期益处：一项积极的治疗扩展研究。
3. Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe [J] . Dominique Joly, Jennifer Quinn, Stella Mokiou, BMC Nephrology . 2020 ,第1期

机译：欧洲综述植物治疗效果，治疗偏好与治疗满意度综合，观察研究衡量的理由及学习议定书
4. Module differences of glucose metabolic brain network among Alzheimer’s disease, Parkinson’s disease dementia, Lewy body dementia and health control* [C] . Danyan Chen, Jiehui Jiang, Ping Wu, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2018

机译：阿尔茨海默氏病，帕金森氏病痴呆症，路易体痴呆症和健康控制之间的葡萄糖代谢性大脑网络的模块差异*
5. Differences in caregiver grief and burden between Dementia with Lewy Bodies, dementia of the Alzheimer's type, and dementia associated with Parkinson's Disease [D] . Rigby, Taylor. 2016

机译：路易体痴呆，阿尔茨海默氏型痴呆和帕金森氏病相关的痴呆之间照料者的悲伤和负担的差异
6. Rivastigmine From Capsules to Patch: Therapeutic Advances in the Management of Alzheimer’s Disease and Parkinson’s Disease Dementia [O] . Carl H. Sadowsky, Joseph L. Micca, George T. Grossberg, 2014

机译：Rivastigmine从胶囊到贴剂：阿尔茨海默氏病和帕金森氏病痴呆症的治疗进展
7. Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily) [O] . Zhen-Xin Zhang, Zhen Hong, Yan-Ping Wang, 2016

机译：中国患有可能的阿尔茨海默病患者的Rivastigmine补丁：24周，随机，双盲并联群体研究将Rivastigmine贴片（9.5mg / 24小时）与胶囊（每日两次）进行比较（6毫克）

AN OPEN-LABELED, OBSERVATIONAL STUDY FOR THE SATISFACTION AND PREFERENCE OF THE RIVASTIGMINE PATCH FOR TREATMENT OF ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE DEMENTIA (SAFE-ADPD) IN KOREANS

著录项

相似文献

相关主题

期刊订阅